OrbiMed is a healthcare investment firm that provides tailored financing solutions and global team resources to help build world-class healthcare companies.

OrbiMed

Break Trail Ventures is an early stage venture fund based in Columbus, OH and Boulder, CO. The fund partners with entrepreneurs who are self-described as breaking trail in their industry, putting the customer first, and solving meaningful problems.

Break Trail Ventures

Newgen Capital is an investment brand that focuses on early-stage venture capital funds, actively participating as a limited partner in various funds, according to self-described characteristics.

Newgen Capital

Rook Quality Systems provides quality management and regulatory support for medical devices, including quality system design, audit support, training, and documentation.

Rook Quality Systems

OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.

Zai Lab

LogicBio Therapeutics

Magenta Therapeutics

BiolineRx

Century Therapeutics

Constellation Pharmaceuticals

Crinetics Pharmaceuticals

Cullinan Oncology

Erasca

Natera

Nautilus Biotechnology

Netmeds

NeuroPace

ORIC Pharmaceuticals

Owlet Baby Care

Terns Pharmaceuticals

Third Harmonic Bio

TigerConnect

Tricida

Valneva

VectivBio

Gelesis

Graphite Bio

Guardant Health

Health Catalyst

Imara

Insmed

Inspire Medical Systems

Intellia Therapeutics

Sierra Oncology

Puma Biotechnology

RedHill Biopharma

ReViral

scPharmaceuticals

Sientra

Syndax Pharmaceuticals

AbCellera

Acutus Medical

Invivyd

Adaptive Biotechnologies

Affimed

Alector

Alpine Immune Sciences

Amolyt Pharma

Arcutis Biotherapeutics

Ascendis Pharma

Athersys

Ventyx Biosciences

ViewRay

Augmedix

Sonendo

Invitae

Kala Pharmaceuticals

Metric
Company Name	OrbiMed	Break Trail Ventures	Newgen Capital	Rook Quality Systems
Symbol
MSH ID	COM:ORBIMED	COM:BREAKTRAILVENTURES	COM:NEWGENVC	COM:ROOKQS
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Financial Services & Finance	Financial Services & Finance	Healthcare & Health Services
Industry	Healthcare Investment	Venture Capital	Venture Capital	Medical Device Consulting
Country	US	US	CN	US
Stage
Employee Count	149
Website	orbimed.com	breaktrailventures.com	newgenvc.com	rookqs.com
LinkedIn	orbimed-advisors	break-trail-ventures	newgen-vc
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic			205
Web Traffic Growth			0.72
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

ORBI

COM:ORBIMED

OrbiMed

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue